Jasper Financial Statements From 2010 to 2025
| JSPR Stock | USD 3.15 0.02 0.64% |
Check Jasper Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jasper Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Jasper financial statements analysis is a perfect complement when working with Jasper Therapeutics Valuation or Volatility modules.
Check out the analysis of Jasper Therapeutics Correlation against competitors. Jasper Therapeutics Company Return On Asset Analysis
Jasper Therapeutics' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Jasper Therapeutics Return On Asset | -0.56 |
Most of Jasper Therapeutics' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Jasper Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Jasper Therapeutics has a Return On Asset of -0.565. This is 93.54% lower than that of the Biotechnology sector and 97.61% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
Jasper Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Jasper Therapeutics's current stock value. Our valuation model uses many indicators to compare Jasper Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Jasper Therapeutics competition to find correlations between indicators driving Jasper Therapeutics's intrinsic value. More Info.Jasper Therapeutics is rated fourth overall in return on equity category among its peers. It also is rated fourth overall in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Jasper Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Jasper Therapeutics Financial Statements
Jasper Therapeutics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Jasper Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Jasper Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Jasper Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. Jasper Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 35 people.
Additional Tools for Jasper Stock Analysis
When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.